Following BDL, mice carrying hepatocyte-specific HIF-1α conditional deletion showed a significant reduction in liver fibrosis versus control mice, as evaluated in terms of the transcript and protein levels of type I collagen and α-smooth muscle actin (αSMA). The gene discussed is ACTA1; the disease is Hepatic fibrosis.